Bank of New York Mellon
PTX

Bank of New York Mellon’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Bank of New York Mellon’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24,584
Closed -$77K – 4482
2017
Q3 		$77K Buy
24,584
+31
+0.1% +$99 ﹤0.01% 4041
2017
Q2 		$99K Sell
24,553
-7,157
-23% -$31.2K ﹤0.01% 4030
2017
Q1 		$118K Buy
31,710
+6,907
+28% +$21.7K ﹤0.01% 3989
2016
Q4 		$48K Buy
24,803
+20,970
+547% +$75.9K ﹤0.01% 4137
2016
Q3 		$24K Sell
3,833
-664
-15% -$4.09K ﹤0.01% 4210
2016
Q2 		$20K Sell
4,497
-9,620
-68% -$62.8K ﹤0.01% 4268
2016
Q1 		$148K Sell
14,117
-3,727
-21% -$74.1K ﹤0.01% 3877
2015
Q4 		$526K Buy
17,844
+2,233
+14% +$67.5K ﹤0.01% 3501
2015
Q3 		$493K Sell
15,611
-256
-2% -$12.2K ﹤0.01% 3592
2015
Q2 		$939K Sell
15,867
-6,939
-30% -$489K ﹤0.01% 3374
2015
Q1 		$2.44M Buy
22,806
+676
+3% +$64.4K ﹤0.01% 2727
2014
Q4 		$2.08M Buy
22,130
+6,675
+43% +$637K ﹤0.01% 2856
2014
Q3 		$1.19M Buy
15,455
+3,663
+31% +$288K ﹤0.01% 3190
2014
Q2 		$1.06M Buy
11,792
+5,606
+91% +$344K ﹤0.01% 3279
2014
Q1 		$331K Sell
6,186
-31
-0.5% -$1.02K ﹤0.01% 3709
2013
Q4 		$157K Buy
6,217
+253
+4% +$6.03K ﹤0.01% 3909
2013
Q3 		$162K Buy
5,964
+1,278
+27% +$41.1K ﹤0.01% 3844
2013
Q2 		$169K Buy
+4,686
New +$176K ﹤0.01% 3809

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon's PTX Position: Q4 2017 in Review

Bank of New York Mellon sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2017, closing a stake of 24,584 shares — an estimated $77K sold.

Bank of New York Mellon first reported a position in PTX in Q2 2013 and held it in 18 quarters. The position peaked at $2.44M in Q1 2015. 30 funds tracked by Wall St. Rank hold PTX as of Q4 2017.

  • Bank of New York Mellon reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 24,584 Pernix Therapeutics Holdings, Inc. shares in Q4 2017, an estimated $77K.
  • Bank of New York Mellon first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 18 quarters.
  • Bank of New York Mellon's Pernix Therapeutics Holdings, Inc. position peaked at $2.44M in Q1 2015.
  • 30 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2017.

Based on Bank of New York Mellon's 13F filing for Q4 2017, filed 9 Feb 2018.